Provet Cloud vs Regeneron Pharmaceuticals

Side-by-side comparison of AI visibility scores, market position, and capabilities

Regeneron Pharmaceuticals leads in AI visibility (79 vs 54)
Provet Cloud logo

Provet Cloud

ChallengerVertical SaaS — Veterinary & Pet Health Tech

Cloud Veterinary Information Management System

Cloud-based veterinary information management system acquired by Nordhealth; Helsinki Finland; serves 3,000+ clinics across Europe, Australia, New Zealand, and North America;

AI VisibilityBeta
Overall Score
C54
Category Rank
#201 of 596
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
52
Perplexity
55
Gemini
48

About

Provet Cloud is a cloud-based veterinary information management system (VIMS) that provides veterinary practices with patient records, appointment scheduling, invoicing, pharmacy management, lab integration, and reporting in a browser-accessible platform, developed and headquartered in Helsinki, Finland and acquired by Nordhealth, the Nordic health technology group. Provet Cloud serves more than 3,000 veterinary clinics across Europe, Australia, New Zealand, and North America, making it one of the most internationally deployed cloud-native veterinary practice management platforms available.\n\nProvet Cloud's platform is designed for general veterinary practices, emergency clinics, and specialty hospitals, offering a clinical workflow that tracks patients from check-in through consultation, diagnostics, treatment, and discharge with integrated invoicing and payment collection. Lab integrations connect directly to in-house analyzers and external diagnostic labs, bringing results into the patient record automatically. The platform's multi-location and multi-user architecture supports corporate veterinary groups and franchise networks that need consolidated reporting across clinics while maintaining individual clinic workflows. APIs allow integration with third-party diagnostic, imaging, and practice growth tools.\n\nAs part of Nordhealth, Provet Cloud benefits from investment in development resources and synergies with Nordhealth's other healthcare technology platforms. Provet Cloud competes with ezyVet (owned by IDEXX), Digitail, Vetspire, and the legacy PIMS offerings from IDEXX and Henry Schein. Its strong presence in European and Australasian markets differentiates it from US-centric competitors, and its API-first architecture appeals to technology-forward practices and corporate groups building integrated technology stacks.

Full profile
Regeneron Pharmaceuticals logo

Regeneron Pharmaceuticals

LeaderHealthcare Tech

Enterprise

Regeneron (REGN) reported $13.9B revenue in FY2024, up 7% YoY. Top biotech company. Dupixent franchise >$14B. Leaders in eye disease, immunology, oncology. HQ: Tarrytown, NY.

AI VisibilityBeta
Overall Score
B79
Category Rank
#30 of 596
AI Consensus
73%
Trend
stable
Per Platform
ChatGPT
77
Perplexity
76
Gemini
75

About

Regeneron Pharmaceuticals, Inc. is a leading biotechnology company specializing in the discovery, development, and commercialization of medicines for serious diseases, headquartered in Tarrytown, New York. Founded in 1988 by Leonard Schleifer and George Yancopoulos, Regeneron developed its own proprietary drug discovery technology platform (VelociGene, VelocImmune) that has enabled the development of multiple breakthrough medicines. The company reported revenues of $13.9B in FY2024, up 7% year-over-year.

Full profile

AI Visibility Head-to-Head

54
Overall Score
79
#201
Category Rank
#30
79
AI Consensus
73
stable
Trend
stable
52
ChatGPT
77
55
Perplexity
76
48
Gemini
75
52
Claude
85
57
Grok
74

Key Details

Category
Cloud Veterinary Information Management System
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Provet Cloud
Cloud Veterinary Information Management System

Integrations

Only Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.